Five more insights:
1. The Nashville, Tenn.-based company has 123 freestanding outpatient surgery centers, the same number it had all year.
2. For 2019, the company’s outpatient surgery caseload increased 4 percent from 971,537 in 2018 to 1,009,947.
3. Outpatient revenues made up 38.7 percent of the company’s patient revenues in the fourth quarter and for the entire year.
4. Same-facility outpatient surgical cases increased 1.8 percent year over year in the fourth quarter, and 1.6 percent year over year for 2019.
5. HCA reported revenues of $13.5 billion for 2019, up from $12.3 billion in 2018.
6. HCA’s board of directors authorized a share repurchase program, looking to purchase up to $2 billion in outstanding common shares. HCA will also pay a quarterly cash dividend of $0.43 per share of common stock.
7. For 2020, the company expects to post full-year revenues of $53.5 billion to $55.5 billion.
Read the entire release here.
More articles on transactions/valuation:
Private equity’s potential impact on orthopedics: 5 surgeons’ views
Outpatient knee replacement innovation: 5 thoughts from DePuy Synthes’ Rajit Kamal
Dr. David Jacofsky on the top opportunities for outpatient orthopedics in 2020
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.